Treatment of superficial ulcerative squamous cell carcinoma in three horses with topical 5-fluorouracil.

The research article presents findings from a study on using topical 5-fluorouracil as a treatment method for superficial ulcerative squamous cell carcinoma in three horses, concluding that the treatment was largely successful.

Research Objective and Methodology

• The primary objective of the research was to assess the effectiveness of topical 5-fluorouracil, a traditional chemotherapy drug, in treating superficial ulcerative squamous cell carcinoma, a common type of skin cancer, in horses.
• The study involved three horses suffering from this type of carcinoma, each treated with topical 5-fluorouracil.

Results of the Study

• All three horses responded well to the treatment, indicating the potential effectiveness of 5-fluorouracil in equine dermatological applications.
• Post treatment, two of the three horses remained in remission and did not require any further treatment.
• The third horse managed to control the condition by applying the cream for seven days once every six weeks.

Side Effects and Reactions

• There were no systemic side effects observed as a result of the treatment. This implies that the usage of topical 5-fluorouracil was relatively safe without impacting the overall health system of the horses adversely.
• However, localized inflammatory reactions were noted in all three cases. This suggests that while the cream is effective, its usage might cause minor skin irritations and inflammation.

Study Implications

• The success of this treatment in all three cases suggests the potential for effective use of topical 5-fluorouracil in treating squamous cell carcinoma in horses.
• The minor localized side effects might warrant further exploration into other potential side effects and long-term ramifications of the cream’s usage.
• Given the study’s limited sample size, further research may be necessary to confirm its effectiveness, understand dosage optimization, and detail any side effects.